HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardium.

AbstractINTRODUCTION:
Pronounced extracellular acidosis reduces both cardiac contractility and the β-adrenergic response. In the past, this was shown in some studies using animal models. However, few data exist regarding how the human end-stage failing myocardium, in which compensatory mechanisms are exhausted, reacts to acute mild metabolic acidosis. The aim of this study was to investigate the effect of mild metabolic acidosis on contractility and the β-adrenergic response of isolated trabeculae from human end-stage failing hearts.
METHODS:
Intact isometrically twitching trabeculae isolated from patients with end-stage heart failure were exposed to mild metabolic acidosis (pH 7.20). Trabeculae were stimulated at increasing frequencies and finally exposed to increasing concentrations of isoproterenol (0 to 1 × 10(-6) M).
RESULTS:
A mild metabolic acidosis caused a depression in twitch-force amplitude of 26% (12.1 ± 1.9 to 9.0 ± 1.5 mN/mm(2); n = 12; P < 0.01) as compared with pH 7.40. Force-frequency relation measurements yielded no further significant differences of twitch force. At the maximal isoproterenol concentration, the force amplitude was comparable in each of the two groups (pH 7.40 versus pH 7.20). However, the half-maximal effective concentration (EC50) was significantly increased in the acidosis group, with an EC50 of 5.834 × 10(-8) M (confidence interval (CI), 3.48 × 10(-8) to 9.779 × 10(-8); n = 9), compared with the control group, which had an EC50 of 1.056 × 10(-8) M (CI, 2.626 × 10(-9) to 4.243 × 10(-8); n = 10; P < 0.05), indicating an impaired β-adrenergic force response.
CONCLUSIONS:
Our data show that mild metabolic acidosis reduces cardiac contractility and significantly impairs the β-adrenergic force response in human failing myocardium. Thus, our results could contribute to the still-controversial discussion about the therapy regimen of acidosis in patients with critical heart failure.
AuthorsHanna Schotola, Karl Toischer, Aron F Popov, André Renner, Jan D Schmitto, Jan Gummert, Michael Quintel, Martin Bauer, Lars S Maier, Samuel Sossalla
JournalCritical care (London, England) (Crit Care) Vol. 16 Issue 4 Pg. R153 (Aug 13 2012) ISSN: 1466-609X [Electronic] England
PMID22889236 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-Agonists
  • Receptors, Adrenergic, beta
  • Isoproterenol
Topics
  • Acidosis (physiopathology)
  • Adrenergic beta-Agonists (administration & dosage)
  • Adult
  • Dose-Response Relationship, Drug
  • Female
  • Heart (physiopathology)
  • Heart Failure (physiopathology)
  • Humans
  • Hydrogen-Ion Concentration
  • In Vitro Techniques
  • Isoproterenol (administration & dosage)
  • Male
  • Middle Aged
  • Myocardial Contraction (drug effects, physiology)
  • Receptors, Adrenergic, beta (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: